[HTML][HTML] A novel aldisine derivative exhibits potential antitumor effects by targeting JAK/STAT3 signaling
DP Wang, LH Wu, R Li, N He, QY Zhang, CY Zhao… - Marine Drugs, 2023 - mdpi.com
The JAK/STAT3 signaling pathway is aberrantly hyperactivated in many cancers, promoting
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
[HTML][HTML] A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling
DP Wang, LH Wu, R Li, N He, QY Zhang, CY Zhao… - Marine …, 2023 - ncbi.nlm.nih.gov
The JAK/STAT3 signaling pathway is aberrantly hyperactivated in many cancers, promoting
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling
DP Wang, LH Wu, R Li, N He, QY Zhang… - Marine …, 2023 - pubmed.ncbi.nlm.nih.gov
The JAK/STAT3 signaling pathway is aberrantly hyperactivated in many cancers, promoting
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling.
DP Wang, LH Wu, R Li, N He, QY Zhang… - Marine …, 2023 - search.ebscohost.com
The JAK/STAT3 signaling pathway is aberrantly hyperactivated in many cancers, promoting
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
[PDF][PDF] A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling
DP Wang, LH Wu, R Li, N He, QY Zhang… - Mar …, 2023 - pdfs.semanticscholar.org
The JAK/STAT3 signaling pathway is aberrantly hyperactivated in many cancers, promoting
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling
W Dong-Ping, W Li-Hong, R Li, N He… - Marine …, 2023 - search.proquest.com
The JAK/STAT3 signaling pathway is aberrantly hyperactivated in many cancers, promoting
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling.
DP Wang, LH Wu, R Li, N He, QY Zhang, CY Zhao… - Marine Drugs, 2023 - europepmc.org
The JAK/STAT3 signaling pathway is aberrantly hyperactivated in many cancers, promoting
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling.
DP Wang, LH Wu, R Li, N He, QY Zhang, CY Zhao… - Marine Drugs, 2023 - europepmc.org
The JAK/STAT3 signaling pathway is aberrantly hyperactivated in many cancers, promoting
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …
cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting …